Black Diamond Therapeutics, Inc. (BDTX)
2.22
+0.03
(+1.37%)
USD |
NASDAQ |
Feb 13, 16:00
2.225
0.00 (0.00%)
After-Hours: 20:00
Black Diamond Therapeutics EPS Diluted (Quarterly) : -0.1493 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bionano Genomics, Inc. | -1.593 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.498M |
| Total Expenses (Quarterly) | 8.498M |
| Enterprise Value | 10.65M |
| Earnings Yield | 16.34% |
| Operating Earnings Yield | 9.37% |
| Normalized Earnings Yield | 16.34 |